Med Plug RX
Division 01Regenerative MedicineUmbilical-derived exosome and cellular preparations, counted and characterized per lot, supplied to a closed physician register.Enter Regenerative MedicineDivision 02PeptidesSeventy-three pharmaceutical-manufactured peptides, pre-filled in a certified injector pen. No vial, no reconstitution.Enter Peptides
Med Plug RX Editorial·6 min read·Med Plug RX Library

Quality Validation and GxP in Biotechnology

Every serious conversation about biologics eventually arrives at three letters: GxP. The x is a placeholder — for Manufacturing, Laboratory, Tissue, Distribution — and the framework behind it determines whether what a supplier claims can be independently believed.

Testing proves a batch. Validation proves the process.

This distinction is the one most often missed. Testing asks whether a particular lot met specification. Validation asks whether the process is capable of producing conforming material reliably, and provides documented evidence that it does.

A supplier that tests but does not validate can tell you their last lot passed. A supplier operating a validated process can tell you why the next one will — and can show the qualification records, the process performance data and the change-control history that support the claim. Only one of those is a quality system.

The relevant frameworks

cGMP governs manufacturing: facility design, environmental monitoring, equipment qualification, batch records, deviation management and release authority. GLP governs the non-clinical laboratory work that generates data, ensuring analytical results are traceable and auditable. GTP — Good Tissue Practice under 21 CFR Part 1271 — governs donor eligibility, screening, testing and the prevention of communicable disease transmission. GDP governs what happens after release: storage, cold chain and distribution integrity.

A biologic derived from donated human tissue passes through all four. A gap in any one of them is a gap in the whole chain, regardless of how strong the others are.

Accreditation as external verification

Internal quality claims are assertions. Accreditation converts them into third-party findings. ISO 9001 addresses the quality management system; ISO/IEC 17025 addresses testing and calibration laboratory competence; ISO 20387 addresses biobanking specifically. An accreditation body such as ANAB assesses against these standards on a recurring cycle, which means the finding has an expiry date and must be re-earned.

How to read a supplier

Four questions separate a documented operation from a marketed one. Which standards are you accredited to, and by whom? Is your process validated, and can you describe the validation approach? Does the certificate of analysis report results measured on my lot, or values representative of the product? And who holds release authority — is it independent of production?

A supplier operating a real quality system finds these questions ordinary. That reaction is itself informative.

Selected Literature
  1. 21 CFR Part 1271 — Human Cells, Tissues, and Cellular and Tissue-Based Products. U.S. Food and Drug Administration
  2. FDA Guidance for Industry: Process Validation — General Principles and Practices. 2011
  3. ISO/IEC 17025:2017 — General requirements for the competence of testing and calibration laboratories
This article is educational material for licensed physicians. It describes published science; it is not a claim that any preparation diagnoses, treats, cures or prevents any disease. Clinical application, indication and patient selection remain the sole responsibility of the treating physician.
Back To The Library Request A Physician Account